(Q39820429)

14 September 2017

Oral and parenteral therapy with saperconazole (R 66905) of invasive aspergillosis in normal and immunocompromised animals (English)

1 reference

14 September 2017

0 references

invasive aspergillosis

1 reference

Van Cutsem J

1

1 reference

14 September 2017

Van Gerven F

series ordinal

2

1 reference

14 September 2017

Janssen PA

series ordinal

3

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 December 1989

1 reference

Antimicrobial Agents and Chemotherapy

14 September 2017

1 reference

14 September 2017

33

1 reference

14 September 2017

12

1 reference

14 September 2017

2063-2068

1 reference

Itraconazole, a new triazole that is orally active in aspergillosis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172822

In vitro studies with R 51,211 (itraconazole)

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172822

Aspergillosis. The spectrum of the disease in 98 patients

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172822

Activity of orally, topically, and parenterally administered itraconazole in the treatment of superficial and deep mycoses: animal models

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172822

Azole antifungal agents: emphasis on new triazoles

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172822

Invasive Aspergillosis in Acute Leukemia: Correlation with Nose Cultures and Antibiotic Use

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172822

Role of animal and human pharmacology in antifungal drug design

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172822

Antifungal Activity of Enilconazole on Experimental Aspergillosis in Chickens

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172822

Antimycotic azoles. 7. Synthesis and antifungal properties of a series of novel triazol-3-ones

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172822

Aspergillus pneumonia in hematologic malignancy. Improvements in diagnosis and therapy

20 August 2018

1 reference

12 December 2020

Itraconazole treatment of murine aspergillosis

1 reference

12 December 2020

In vitro activity of enilconazole against Aspergillus spp. and its fungicidal efficacy in a smoke generator against Aspergillus fumigatus

1 reference

12 December 2020

Antifungal relative inhibition factors: BAY l-9139, bifonazole, butoconazole, isoconazole, itraconazole (R 51211), oxiconazole, Ro 14-4767/002, sulconazole, terconazole and vibunazole (BAY n-7133) compared in vitro with nine established antifungal a

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.33.12.2063

1 reference

14 September 2017

1 reference

14 September 2017

PubMed publication ID

2619273

1 reference